Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
2.91B | 2.76B | 2.52B | 2.11B | 1.45B | 973.97M | Gross Profit |
2.30B | 2.19B | 1.98B | 1.64B | 1.09B | 730.74M | EBIT |
178.52M | 31.63M | -55.16M | -60.47M | -173.85M | -193.51M | EBITDA |
330.40M | 195.59M | 2.76M | 21.44M | -127.60M | -124.12M | Net Income Common Stockholders |
1.01B | 73.98M | -97.45M | -69.98M | -243.27M | -208.36M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
1.05B | 1.05B | 1.03B | 802.82M | 773.50M | 656.14M | Total Assets |
2.97B | 2.97B | 3.01B | 2.54B | 2.34B | 1.89B | Total Debt |
143.05M | 143.05M | 888.29M | 882.23M | 915.75M | 648.48M | Net Debt |
-654.01M | -654.01M | 166.40M | 373.17M | 349.70M | 407.28M | Total Liabilities |
1.84B | 1.84B | 2.40B | 2.27B | 2.01B | 1.34B | Stockholders Equity |
1.13B | 1.13B | 617.29M | 275.50M | 325.74M | 546.33M |
Cash Flow | Free Cash Flow | ||||
914.58M | 887.13M | 429.11M | 445.07M | 214.56M | 43.65M | Operating Cash Flow |
1.01B | 979.53M | 506.76M | 506.47M | 296.95M | 115.70M | Investing Cash Flow |
-213.35M | 44.61M | -191.20M | -162.91M | 81.23M | -321.49M | Financing Cash Flow |
-1.37B | -946.04M | -98.26M | -394.62M | -58.98M | -70.45M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $16.80B | 16.83 | 50.85% | ― | 7.52% | 1855.81% | |
79 Outperform | $171.61B | 57.36 | 16.92% | 0.65% | 13.73% | 9.93% | |
78 Outperform | $193.98B | 35.94 | 39.42% | ― | 11.02% | 4.96% | |
73 Outperform | $22.64B | 23.40 | 11.31% | ― | 3.05% | 55.96% | |
69 Neutral | $4.70B | 40.89 | 1086.23% | ― | 4.09% | 299.27% | |
68 Neutral | $7.82B | 18.77 | -60.11% | ― | 1.86% | 6.21% | |
59 Neutral | $22.39B | 11.53 | -18.05% | 2.31% | 5.00% | -25.89% |
On January 15, 2025, DocuSign’s Board of Directors approved amendments to the Executive Severance and Change in Control Agreements for key executives, including the CFO, President, and Chief Legal Officer. These restated agreements make permanent certain enhancements for qualifying terminations outside and during a change in control period, impacting severance benefits including salary, bonus, COBRA coverage, and equity award vesting.